1 |
SARKAR A, HOCHEDLINGER K. The sox family of transcription factors:versatile regulators of stem and progenitor cell fate[J].Cell Stem Cell,2013,12(1):15-30.
|
2 |
SCHEPERS G E, TEASDALE R D, KOOPMAN P. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families[J]. Dev Cell, 2002, 3(2): 167-170.
|
3 |
CAI J L, LIANG J Y, ZHANG Y T, et al. Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways[J]. Pharmacol Res, 2022, 180: 106230.
|
4 |
SUN X G, SUN B L, BABICHEVA A, et al. Direct extracellular NAMPT involvement in pulmonary hypertension and vascular remodeling. transcriptional regulation by SOX and HIF-2α[J]. Am J Respir Cell Mol Biol, 2020, 63(1): 92-103.
|
5 |
LAARMAN M D, GEEVEN G, BARNETT P, et al. Chromatin conformation links putative enhancers in intracranial aneurysm-associated regions to potential candidate genes[J].J Am Heart Assoc,2019,8(9):e011201.
|
6 |
GARCÍA-RAMÍREZ M, MARTÍNEZ-GONZÁLEZ J, JUAN-BABOT J O, et al. Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth[J]. Arterioscler Thromb Vasc Biol,2005,25(11):2398-2403.
|
7 |
LU P F, WANG P, WU B R, et al. A SOX17-PDGFB signaling axis regulates aortic root development[J]. Nat Commun, 2022, 13(1): 4065.
|
8 |
CORADA M, ORSENIGO F, BHAT G P, et al. Fine-tuning of Sox17 and canonical Wnt coordinates the permeability properties of the blood-brain barrier[J]. Circ Res, 2019, 124(4): 511-525.
|
9 |
MONTANI D, LECHARTIER B, GIRERD B, et al. An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants[J]. Eur Respir J, 2022, 60(6): 2200656.
|
10 |
SABATER-LLEAL M, HUFFMAN J E, DE VRIES P S, et al. Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor Ⅷ and von willebrand factor plasma levels[J]. Circulation, 2019, 139(5): 620-635.
|
11 |
LANGEN U H, AYLOO S, GU C H. Development and cell biology of the blood-brain barrier[J]. Annu Rev Cell Dev Biol, 2019, 35: 591-613.
|
12 |
LEE S H, LEE S, YANG H, et al. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis[J]. Circ Res, 2014, 115(2): 215-226.
|
13 |
XU Z, RUI Y N, HAGAN J P, et al. Intracranial aneurysms: pathology, genetics, and molecular mechanisms[J].Neuromolecular Med, 2019,21(4): 325-343.
|
14 |
KARSCHNIA P, NISHIMURA S, LOUVI A. Cerebrovascular disorders associated with genetic lesions[J]. Cell Mol Life Sci, 2019, 76(2): 283-300.
|
15 |
LIU M L, ZHANG L H, MARSBOOM G, et al. Sox17 is required for endothelial regeneration following inflammation-induced vascular injury[J]. Nat Commun, 2019, 10(1): 2126.
|
16 |
NATARELLI L, GEIßLER C, CSABA G, et al. miR-103 promotes endothelial maladaptation by targeting lncWDR59[J]. Nat Commun, 2018, 9(1): 2645.
|
17 |
RITZ K, DENSWIL N P, STAM O C G, et al. Cause and mechanisms of intracranial atherosclerosis[J]. Circulation, 2014, 130(16): 1407-1414.
|
18 |
RIVAS-URBINA A, RULL A, ORDÓÑEZ-LLANOS J,et al. Electronegative LDL:an active player in atherogenesis or a by-product of atherosclerosis?[J].Curr Med Chem,2019,26(9): 1665-1679.
|
19 |
WANG J Y, LAI C L, LEE C T, et al. Electronegative low-density lipoprotein L5 impairs viability and NGF-induced neuronal differentiation of PC12 cells via LOX-1[J]. Int J Mol Sci, 2017, 18(8): 1744.
|
20 |
SHAO C L, WANG J J, TIAN J, et al. Coronary artery disease: from mechanism to clinical practice[J]. Adv Exp Med Biol, 2020, 1177: 1-36.
|
21 |
KONG P, CUI Z Y, HUANG X F, et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention[J]. Signal Transduct Target Ther, 2022, 7(1): 131.
|
22 |
ZHANG Y, WU H K, HE R, et al. Dickkopf-2 knockdown protects against classic macrophage polarization and lipid loading by activation of Wnt/ β-catenin signaling[J]. J Cardiol, 2021, 78(4): 328-333.
|
23 |
VIECELI DALLA SEGA F, FORTINI F, AQUILA G,et al. Notch signaling regulates immune responses in atherosclerosis[J]. Front Immunol, 2019, 10: 1130.
|